Pages that link to "Q38585651"
Jump to navigation
Jump to search
The following pages link to Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy (Q38585651):
Displaying 50 items.
- Review: Multiple system atrophy: emerging targets for interventional therapies (Q26770919) (← links)
- Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation (Q26771536) (← links)
- Multiple system atrophy: a clinical and neuropathological perspective (Q26829838) (← links)
- Glia and alpha-synuclein in neurodegeneration: A complex interaction (Q26851153) (← links)
- Alpha-synuclein biology in Lewy body diseases (Q27003541) (← links)
- Animal models of multiple system atrophy (Q27015535) (← links)
- Animal modeling an oligodendrogliopathy--multiple system atrophy (Q28074659) (← links)
- Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy (Q30516504) (← links)
- Distinct Parameters in the EEG of the PLP α-SYN Mouse Model for Multiple System Atrophy Reinforce Face Validity (Q30834391) (← links)
- Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration (Q33253340) (← links)
- Modulation of alpha-synuclein expression in transgenic animals for modelling synucleinopathies--is the juice worth the squeeze? (Q33392127) (← links)
- Mesenchymal stem cells can modulate longitudinal changes in cortical thickness and its related cognitive decline in patients with multiple system atrophy. (Q33750881) (← links)
- Towards translational therapies for multiple system atrophy (Q33797532) (← links)
- Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates (Q33805560) (← links)
- α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy (Q33864597) (← links)
- Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy (Q33868678) (← links)
- Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy (Q33914242) (← links)
- Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection (Q33916838) (← links)
- Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure (Q34032393) (← links)
- The neuropathology, pathophysiology and genetics of multiple system atrophy (Q34231585) (← links)
- A randomized trial of mesenchymal stem cells in multiple system atrophy. (Q34290126) (← links)
- Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies (Q34450431) (← links)
- Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy (Q34491408) (← links)
- FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy (Q34571668) (← links)
- Modelling progressive autonomic failure in MSA: where are we now? (Q34626244) (← links)
- Novel therapeutic approaches in multiple system atrophy (Q34696470) (← links)
- Toll-like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neurons (Q35167964) (← links)
- Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype (Q35819324) (← links)
- Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity (Q35857994) (← links)
- Neuroprotective Effect of a DJ-1 Based Peptide in a Toxin Induced Mouse Model of Multiple System Atrophy (Q35931008) (← links)
- Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications (Q35952063) (← links)
- Management of multiple system atrophy: state of the art. (Q36311957) (← links)
- Models of multiple system atrophy (Q36513407) (← links)
- Large-scale mitochondrial DNA deletion underlying familial multiple system atrophy of the cerebellar subtype (Q36530678) (← links)
- Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum (Q36541685) (← links)
- Bladder dysfunction in a transgenic mouse model of multiple system atrophy. (Q36549533) (← links)
- Mechanisms and models of alpha-synuclein-related neurodegeneration. (Q36575028) (← links)
- Cellular pathology in multiple system atrophy (Q36589164) (← links)
- alpha-Synucleinopathy models and human neuropathology: similarities and differences (Q36969122) (← links)
- Up-regulation of SNCA gene expression: implications to synucleinopathies (Q37004246) (← links)
- Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy (Q37213903) (← links)
- Molecular mechanisms of alpha-synuclein neurodegeneration (Q37309838) (← links)
- Molecular and cellular biology of synucleins (Q37350413) (← links)
- Recent developments in multiple system atrophy. (Q37496792) (← links)
- Lipid dysfunction and pathogenesis of multiple system atrophy (Q37580065) (← links)
- Multiple system atrophy: an update. (Q37631965) (← links)
- Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts (Q37874476) (← links)
- Milestones in atypical and secondary Parkinsonisms (Q37882597) (← links)
- Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications (Q37898719) (← links)
- The role of glia in α-synucleinopathies (Q38039880) (← links)